GSK962040
Sponsors
GlaxoSmithKline
Conditions
Gastroparesis
Phase 1
A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040
CompletedNCT00562848
Start: 2007-09-10End: 2008-06-27Updated: 2017-08-08
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
CompletedNCT00733551
Start: 2008-09-23End: 2009-07-20Updated: 2017-07-18
GSK962040 Drug-drug Interaction Study With Ketoconazole
CompletedNCT01039974
Start: 2009-09-18End: 2009-11-30Updated: 2017-06-20